PECAM1 and osteosarcoma: Immunohistochemistry on post-chemotherapy tumor resection specimens showed the expression of VEGF in all 16 treated osteosarcomas, albeit with different degrees of staining in viable tumor cells, and of CD31 in microvessels, even in specimens that were VEGF and/or CD31-negative at biopsy (Figure 4).